Literature DB >> 20520297

Risperidone long-acting injectable in recent-onset schizophrenia examined with clinician and patient self-report measures.

Oleksandr Napryeyenko, Benjaminas Burba, Guadalupe Martinez, Nikolay G Neznanov, Tsvi Fischel, Franck J Baylé, Giulio Corrivetti, Enrico Smeraldi, Jonathan Rabinowitz, Andreas Schreiner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20520297     DOI： 10.1097/JCP.0b013e3181d438e2

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  6 in total

1.  Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics and Suicide and All-Cause Mortality in Patients With Newly Diagnosed Schizophrenia.

Authors:  Cheng-Yi Huang; Su-Chen Fang; Yu-Hsuan Joni Shao
Journal:  JAMA Netw Open       Date:  2021-05-03

2.  Long-acting injectable antipsychotics for first-episode schizophrenia: the pros and cons.

Authors:  Borah Kim; Sang-Hyuk Lee; Yen Kuang Yang; Jong-Il Park; Young-Chul Chung
Journal:  Schizophr Res Treatment       Date:  2012-08-14

Review 3.  Long-acting injectable antipsychotics for early psychosis: A comprehensive systematic review.

Authors:  Lulu Lian; David D Kim; Ric M Procyshyn; Diana Cázares; William G Honer; Alasdair M Barr
Journal:  PLoS One       Date:  2022-04-29       Impact factor: 3.240

Review 4.  Clinical benefits and impact of early use of long-acting injectable antipsychotics for schizophrenia.

Authors:  Georgia L Stevens; Gail Dawson; Jacqueline Zummo
Journal:  Early Interv Psychiatry       Date:  2015-09-25       Impact factor: 2.732

5.  Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia.

Authors:  Jennifer Kern Sliwa; Cynthia A Bossie; Dong-Jing Fu; Ibrahim Turkoz; Larry Alphs
Journal:  Neuropsychiatr Dis Treat       Date:  2012-08-27       Impact factor: 2.570

Review 6.  Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life.

Authors:  Cristiana Montemagni; Tiziana Frieri; Paola Rocca
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-19       Impact factor: 2.570
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.